
    
      The study is prospective, parallel, double-blind, randomized, placebo-controlled analysis
      with intent to treat. There are 2 groups:

        -  A group N: néfopam

        -  A group P: placebo And all the patient receive, before randomization, 100 mg of
           ketoprofen (Profenid ®) on 20 minutes.

      The number of subjects is 52.
    
  